5/15/24 17:49 | 5/13/24 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Diaz Paul J | UT | DO | P,CEO | 1 | S.m | -5,729 | 25.14 | 0 | -228 | | 1,066 | D | | | | | | | | | | | | | | |
5/15/24 17:48 | 5/13/24 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Newcomer Lee Nisley | UT | D | | 1 | S | -157 | 25.30 | 0 | -6 | | 67 | D | | | | | | | | | | | | | | |
5/15/24 17:09 | 5/13/24 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Sabens Andrea | MA | O | Chief Ac | 3 | S | -68 | 66.20 | 0 | -1 | | 63 | D | | | | | | | | | | | | | | |
5/8/24 19:02 | 5/6/24 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Vandebroek Sophie V. | ME | D | | 3 | M.d | 1,136 | 370.48 | 0 | 3 | 47 | 10 | D | | | | | | | | | | | | | | |
5/8/24 19:02 | 5/6/24 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Kingsley Lawrence D | ME | D | | 1 | M.d | 0 | 0.00 | 0 | 0 | 4 | 9 | D | | | | | | | | | | | | | | |
5/8/24 19:01 | 5/6/24 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Essig Stuart | ME | D | | 1 | M.d | 0 | 0.00 | 0 | 0 | 15 | 2 | D | | | | | | | | | | | | | | |
5/8/24 19:01 | 5/6/24 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Collins Asha | ME | D | | 1 | M.d | 0 | 0.00 | 0 | 0 | 49 | 1 | D | | | | | | | | | | | | | | |
5/8/24 19:00 | 5/6/24 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Britt Irene Chang | ME | D | | 1 | M.d | 0 | 0.00 | 0 | 0 | | 0 | D | | | | | | | | | | | | | | |
5/8/24 19:00 | 5/6/24 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | D | | 1 | M.d | 0 | 0.00 | 0 | 0 | 0 | 578 | D | | | | | | | | | | | | | | |
4/26/24 12:50 | 4/25/24 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Adent John Edward | MI | O | CEO | 2 | M.d | 309 | 12.32 | 0 | 25 | 17 | 171 | D | | | | | | | | | | | | | | |
4/26/24 12:38 | 4/25/24 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Jones Douglas Edward | MI | O | COO | 2 | M.d | 134 | 12.33 | 0 | 11 | 30 | 47 | D | | | | | | | | | | | | | | |
4/26/24 09:48 | 4/25/24 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Rocklin Amy M | MI | O | GC | 1 | M.d | 7 | 11.96 | 0 | 1 | 6 | 10 | D | | | | | | | | | | | | | | |
4/23/24 16:39 | 4/19/24 | ACHV | Achieve Life Sciences, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Wan Jerry | A1 | O | Principa | 1 | M.d | 0 | 0.00 | 0 | 6 | 135 | 10 | D | | | | | | | | | | | | | | |
4/23/24 16:35 | 4/19/24 | ACHV | Achieve Life Sciences, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Jacobs Cindy | WA | DO | P,CMO | 1 | M.d | 0 | 0.00 | 0 | 16 | 114 | 31 | D | | | | | | | | | | | | | | |
4/23/24 16:31 | 4/19/24 | ACHV | Achieve Life Sciences, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Stewart Richard Alistair | WA | DO | Exec CB | 2 | M.d | 46 | 1.41 | 0 | 33 | 177 | 51 | D | | | | | | | | | | | | | | |
4/23/24 16:26 | 4/19/24 | ACHV | Achieve Life Sciences, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bencich John | WA | DO | CEO | 2 | M.d | 46 | 1.31 | 0 | 35 | 58 | 96 | D | | | | | | | | | | | | | | |
4/16/24 18:18 | 4/12/24 | QDEL | Quidelortho Corp | | Health | Diagn | In Vitro & In Vivo Diagnostic | Buechler Kenneth F | CA | D | | 1 | M.d | 190 | 21.07 | 0 | 9 | 12 | 84 | D | | | | | | | | | | | | | | |
4/15/24 19:21 | 4/11/24 | OCX | Oncocyte Corp | CA | Health | Diagn | In Vitro & In Vivo Diagnostic | Broadwood Partners, L.P. | NY | T | | 1 | P.d | 7,058 | 2.92 | 0 | 2,420 | 33 | 9,858 | M | | | | | | | | | | | | | | |
4/15/24 06:04 | 4/11/24 | OCX | Oncocyte Corp | CA | Health | Diagn | In Vitro & In Vivo Diagnostic | Riggs Josh | CA | DO | CEO,P | 1 | P | 10 | 2.95 | 0 | 3 | 999% | 4 | D | | | | | | | | | | | | | | |
4/15/24 06:02 | 4/11/24 | OCX | Oncocyte Corp | CA | Health | Diagn | In Vitro & In Vivo Diagnostic | Arno Andrew | CA | D | | 1 | P | 100 | 2.95 | 0 | 34 | 67 | 85 | D | | | | | | | | | | | | | | |
4/11/24 11:40 | 4/11/24 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Borel James C | DE | D | | 1 | P | 98 | 13.06 | 0 | 8 | 54 | 21 | D | | | | | | | | | | | | | | |
4/10/24 16:18 | 4/10/24 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Naemura David H. | MI | O | CFO | 1 | P | 156 | 12.51 | 0 | 13 | 71 | 30 | D | | | | | | | | | | | | | | |
4/8/24 15:28 | 3/31/24 | CDIO | Cardio Diagnostics Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Burton Paul Frederick | IL | D | | 1 | M.d | 13 | 1.42 | 0 | 9 | | 9 | D | | | | | | | | | | | | | | |
4/8/24 15:22 | 3/31/24 | CDIO | Cardio Diagnostics Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Lau Stanley K. | IL | D | | 1 | M.d | 13 | 1.42 | 0 | 9 | 10 | 100 | D | | | | | | | | | | | | | | |
4/8/24 15:07 | 3/31/24 | CDIO | Cardio Diagnostics Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Intrater James | IL | D | | 1 | M.d | 13 | 1.42 | 0 | 9 | 14 | 72 | D | | | | | | | | | | | | | | |
4/8/24 14:59 | 3/31/24 | CDIO | Cardio Diagnostics Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Levy Oded | IL | D | | 1 | M.d | 13 | 1.42 | 0 | 9 | 14 | 72 | D | | | | | | | | | | | | | | |
3/19/24 16:30 | 3/15/24 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Marshall Robert J. Jr. | MA | O | CFO,Trea | 1 | S | -1,200 | 60.00 | 0 | -20 | | 114 | D | | | | | | | | | | | | | | |
3/11/24 16:30 | 3/7/24 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Blanchfield Paul | MA | O | P | 1 | S | -1,117 | 61.96 | 0 | -18 | | 103 | D | | | | | | | | | | | | | | |
3/8/24 11:24 | 3/6/24 | CATX | Perspective Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Lantheus Alpha Therapy, LLC | MA | T | | 1 | P | 57,409 | 0.9500 | 0 | 60,431 | 107 | 116,773 | D | | | | | | | | | | | | | | |
3/7/24 17:00 | 3/6/24 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Polewaczyk James F | ME | O | EVP | 2 | M.d | 7,949 | 490.45 | 0 | 16 | | 11 | D | | | | | | | | | | | | | | |
3/7/24 17:00 | 3/6/24 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Polewaczyk James F | ME | O | EVP | 2 | S.d | -7,949 | 490.45 | 0 | -16 | | 11 | D | | | | | | | | | | | | | | |
3/7/24 16:30 | 3/5/24 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Leno Sam R | MA | D | | 4 | M.dm | 2,238 | 42.26 | 0 | 53 | 999% | 58 | D | | | | | | | | | | | | | | |
3/7/24 16:30 | 3/5/24 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Leno Sam R | MA | D | | 4 | S.dm | -2,238 | 42.26 | 0 | -53 | | 58 | D | | | | | | | | | | | | | | |
3/5/24 20:28 | 3/4/24 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Heino Mary Anne | MA | D | | 1 | S | -6,130 | 65.31 | 0 | -94 | | 631 | D | | | | | | | | | | | | | | |
3/5/24 16:10 | 3/4/24 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Basta James | MA | O | EVP,GC | 1 | S.d | -76 | 32.99 | 0 | -2 | | 82 | D | | | | | | | | | | | | | | |
3/5/24 16:10 | 3/4/24 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Clark Eliana | MA | O | EVP,Chie | 1 | S.d | -20 | 32.99 | 0 | -1 | | 71 | D | | | | | | | | | | | | | | |
2/27/24 16:21 | 8/15/22 | TKNO | Alpha Teknova, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Grossman Paul David | CA | D | | 1 | P.m | 50 | 5.37 | 0 | 9 | | 9 | D | | | | | | | | | | | | | | |
2/26/24 18:48 | 2/23/24 | QDEL | Quidelortho Corp | | Health | Diagn | In Vitro & In Vivo Diagnostic | Busky Joseph M | CA | O | CFO | 1 | P | 100 | 46.35 | 0 | 2 | 54 | 6 | I | | | | | | | | | | | | | | |
2/22/24 17:02 | 2/21/24 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Mazelsky Jonathan Jay | ME | DO | P,CEO | 1 | M.d | 100 | 206.94 | 0 | 0 | 1 | 82 | D | | | | | | | | | | | | | | |
2/20/24 17:01 | 2/16/24 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Underberg Sharon E. | ME | O | EVP,GC,C | 1 | M.d | 100 | 206.94 | 0 | 0 | 9 | 6 | D | | | | | | | | | | | | | | |
2/20/24 17:00 | 2/15/24 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | McKeon Brian P | ME | O | EVP,CFO, | 1 | M.d | 100 | 206.94 | 0 | 0 | 1 | 49 | D | | | | | | | | | | | | | | |